We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
+7.64%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$2.5B
AUM Growth
+$144M
(+6.1%)
Cap. Flow
+$16.9M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
23.95%
Holding
453
New
26
Increased
85
Reduced
124
Closed
20
Top Buys
| 1 |
Eli Lilly
LLY
|
+$23M |
| 2 |
Novavax
NVAX
|
+$18.4M |
| 3 |
iQIYI
IQ
|
+$17.4M |
| 4 |
Cboe Global Markets
CBOE
|
+$17M |
| 5 |
Netflix
NFLX
|
+$16.8M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
+$27.7M |
| 2 |
Roku
ROKU
|
+$20.6M |
| 3 |
Simon Property Group
SPG
|
+$16.5M |
| 4 |
NIO
NIO
|
+$15.7M |
| 5 |
Moderna
MRNA
|
+$13.5M |
Sector Composition
| 1 | Consumer Staples | 21.66% |
| 2 | Healthcare | 21% |
| 3 | Consumer Discretionary | 11.38% |
| 4 | Communication Services | 9.41% |
| 5 | Materials | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Waste Management
WM
$96.1B
| $202K | 0.01% |
1,445
| – | – |
|
202
Humana
HUM
$48B
| $200K | 0.01% |
452
| – | – |
|
203
Ford
F
$56.7B
| $197K | 0.01% |
13,283
| – | – |
|
204
HCA Healthcare
HCA
$82.3B
| $187K | 0.01% |
906
| – | – |
|
205
Idexx Laboratories
IDXX
$44.8B
| $182K | 0.01% |
288
| – | – |
|
206
Dollar General
DG
$27.7B
| $180K | 0.01% |
830
| – | – |
|
207
Vertex Pharmaceuticals
VRTX
$123B
| $180K | 0.01% |
893
| – | – |
|
208
Centene
CNC
$32.8B
| $174K | 0.01% |
2,389
+448
| +23% | +$30.7K |
|
|
BNY
209
Bank of New York Mellon
BNY
$108B
| $161K | 0.01% |
3,135
| – | – |
|
210
Intel
INTC
$478B
| $159K | 0.01% |
2,832
-701
| -20% | -$41.1K |
|
211
New Oriental
EDU
$7.82B
| $157K | 0.01% |
+1,912
| New | +$232K |
|
212
eBay
EBAY
$49.8B
| $155K | 0.01% |
2,208
| – | – |
|
213
Salesforce
CRM
$140B
| $153K | 0.01% |
628
-160
| -20% | -$36.9K |
|
214
SLB Ltd
SLB
$70.3B
| $152K | 0.01% |
4,745
| – | – |
|
215
Ross Stores
ROST
$74.9B
| $148K | 0.01% |
1,193
| – | – |
|
216
Chevron
CVX
$373B
| $146K | 0.01% |
1,398
-374
| -21% | -$39.5K |
|
217
Travelers Companies
TRV
$78.5B
| $145K | 0.01% |
967
| – | – |
|
218
Electronic Arts
EA
$52.4B
| $144K | 0.01% |
1,003
| – | – |
|
219
Veeva Systems
VEEV
$31.7B
| $143K | 0.01% |
460
| – | – |
|
220
O'Reilly Automotive
ORLY
$71.3B
| $142K | 0.01% |
3,750
| – | – |
|
221
Etsy
ETSY
$7.98B
| $141K | 0.01% |
685
-1,599
| -70% | -$296K |
|
222
ResMed
RMD
$28.9B
| $139K | 0.01% |
562
| – | – |
|
223
Baxter International
BAX
$11.7B
| $133K | 0.01% |
1,649
| – | – |
|
224
Sysco
SYY
$39.1B
| $133K | 0.01% |
1,717
| – | – |
|
225
Sempra
SRE
$60.3B
| $131K | 0.01% |
1,980
| – | – |
|
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI
TOBAM's Q2 2021 Portfolio in Review
As of Q2 2021, TOBAM held 453 positions worth $2.5B, up 6.1% from $2.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
TOBAM's Q2 2021 filing shows 26 new, 85 increased, 124 reduced and 20 closed positions. Its largest new stake was GFL Environmental: 313,947 shares worth $10M. The largest sale was Sarepta Therapeutics, an estimated $27.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- TOBAM's largest Q2 2021 buy was GFL Environmental: 313,947 shares worth $10M.
- TOBAM added most to Eli Lilly in Q2 2021, an estimated $23M increase.
- TOBAM's biggest Q2 2021 reduction was Roku, cutting an estimated $20.6M.
- TOBAM fully exited Sarepta Therapeutics in Q2 2021, selling an estimated $27.7M.
- TOBAM's ten largest holdings make up 24% of its $2.5B portfolio in Q2 2021.
- TOBAM opened 26 new positions and closed 20 in Q2 2021.
- TOBAM's portfolio value rose 6.1% quarter-over-quarter to $2.5B.
Based on TOBAM's 13F filing for Q2 2021, filed 11 Aug 2021.